- Synthesis and biological evaluation of new symmetric curcumin derivatives
-
A series of novel curcumin bisacetamides aiming of enriching their biological activities have been synthesized. The synthesized compounds were screened for their in vitro antioxidant, anti-inflammatory and cytotoxic activities. All the compounds exhibited
- Sribalan, Rajendran,Kirubavathi, Maruthan,Banuppriya, Govindharaj,Padmini, Vediappen
-
-
Read Online
- Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders
-
In the present study, two structurally diverse novel glitazones were designed and synthesized for activation of central PGC-1α signaling through stimulation of PPAR-γ receptor. The functional interaction between PGC-1α and PPAR-γ is a key interaction in the normal physiology of neuroprotective mechanism. Therefore, activation of PPAR-γ–dependent PGC-1α co-activator signaling could be an effective strategy to exhibit neuroprotection in several neurodegenerative disorders like Alzheimer’s disease, Parkinson’s disease, and cerebral ischemia. As part of rational design, analogs were designed manually based on principles of bioisosterism, followed by virtually screened using docking to predict the mode of interaction of compound towards the binding site and molecular dynamic simulation to observe the structural changes that occur during compound interaction with active site. The designed two glitazones (G1, G2) were synthesized and structurally analyzed. As part of evaluation, synthesized glitazones were subjected for preliminary neuroprotective evaluation in Lipopolysaccharide (LPS) intoxicated SH-SY5Y neuroblastoma cells. The results indicate that pre-treatment with synthesized glitazones have increased the percentage cell viability, protected the cell morphology, and decreased the release of pro-inflammatory cytokines (IL-1β, TNF-α), lipid peroxide (LPO), and nitric oxide (NO) level in LPS intoxicated SH-SY5Y cells. Interestingly, among the two glitazones, G2 has shown significant neuroprotection in comparison to G1 and neuroprotective effect exerted by G2 was similar and comparable with the standard pioglitazone. Altogether, neuroprotection exhibited by this non-thiazolidione–based glitazones during neuroinflammatory conditions may be attributed to the activation of central PGC-1α signaling via PPAR-γ receptor.
- Bharathi, Jeyabalan Jeyaram,Dhivya, S.,Divakar, Selvaraj,Durai, Priya,Justin, Antony,Kabadi, Pradeep,Mandal, Subhankar,Prabitha, P.,Prashantha Kumar, B. R.,Sandhya, C. H.,Sekhar, Satheesh John,Wadhwani, Ashish D.,Yuvaraj, S.
-
-
Read Online
- NO Donor compound as well as preparation method and application thereof
-
The invention discloses NO donor compounds and a preparation method and application thereof, wherein the compound is a drug active component formed by splicing 5 - monoisosorbide mononitrate and NIT type nitroxide radicals, and the structure is shown I. A
- -
-
Paragraph 0083; 0084
(2021/11/26)
-
- Iridium-catalysed primary alcohol oxidation and hydrogen shuttling for the depolymerisation of lignin
-
Lignin is a potentially abundant renewable resource for the production of aromatic chemicals, however its selective depolymerisation is challenging. Here, we report a new catalytic system for the depolymerisation of lignin to novel, non-phenolic monoaromatic products based on the selective β-O-4 primary alcohol dehydrogenation with a Cp?Ir-bipyridonate catalyst complex under basic conditions. We show that this system is capable of promoting the depolymerisation of model compounds and isolated lignins via a sequence of selective primary alcohol dehydrogenation, retro-aldol (Cα-Cβ) bond cleavage and in situ stabilisation of the aldehyde products by transfer (de)hydrogenation to alcohols and carboxylic acids. This method was found to give good to excellent yields of cleavage products with both etherified and free-phenolic lignin model compounds and could be applied to real lignin to generate a range of novel non-phenolic monomers including diols and di-acids. We additionally show, by using the same catalyst in a convergent, one-pot procedure, that these products can be selectively channelled towards a single di-acid product, giving much simpler product mixtures as a result.
- Lancefield, Christopher S.,Teunissen, Lucas W.,Weckhuysen, Bert M.,Bruijnincx, Pieter C. A.
-
p. 3214 - 3221
(2018/07/31)
-
- blue calyx a su-glucose derivative and its preparation method and application
-
The invention relates to glucose derivatives of glaucocalyxin A. The glucose derivatives have a structure represented by a formula I or a formula II, wherein R1 represents hydrogen or methoxyl, R2 represents hydrogen or acetyl, and n represents 0 or 1. Th
- -
-
Paragraph 0111; 0112
(2017/08/25)
-
- Influence of a curcumin derivative on hIAPP aggregation in the absence and presence of lipid membranes
-
The deposition of aggregates of human islet amyloid polypeptide (hIAPP) has been correlated with the death of β-cells in type II diabetes mellitus. The actual molecular mechanism of cell death remains largely unknown; however, it has been postulated that
- Pithadia, Amit S.,Bhunia, Anirban,Sribalan, Rajendran,Padmini, Vediappen,Fierke, Carol A.,Ramamoorthy, Ayyalusamy
-
supporting information
p. 942 - 945
(2016/01/20)
-
- Design, synthesis, and biological evaluation of thiazolidine-2,4-dione conjugates as PPAR-γ agonists
-
A library of synthesized conjugates of phenoxy acetic acid and thiazolidinedione 5a-m showed potent peroxisome proliferator activated receptor-γ (PPAR-γ) transactivation as well as significant blood glucose lowering effect comparable to the standard drugs pioglitazone and rosiglitazone. Most of the compounds showed higher docking scores than the standard drug rosiglitazone in the molecular docking study. Compounds 5l and 5m exhibited PPAR-γ transactivation of 54.21 and 55.41%, respectively, in comparison to the standard drugs pioglitazone and rosiglitazone, which showed 65.94 and 82.21% activation, respectively. Compounds 5l and 5m significantly lowered the blood glucose level of STZ-induced diabetic rats. Compounds 5l and 5m lowered the AST, ALT, and ALP levels more than the standard drug pioglitazone. PPAR-γ gene expression was significantly increased by compound 5m (2.00-fold) in comparison to the standard drugs pioglitazone (1.5-fold) and rosiglitazone (1.0-fold). Compounds 5l and 5m did not cause any damage to the liver and could be considered as promising candidates for the development of new antidiabetic agents.
- Nazreen, Syed,Alam, Mohammad Sarwar,Hamid, Hinna,Yar, Mohammad Shahar,Dhulap, Abhijeet,Alam, Perwez,Pasha, Mohammad Abdul Qadar,Bano, Sameena,Alam, Mohammad Mahboob,Haider, Saqlain,Kharbanda, Chetna,Ali, Yakub,Pillai, Kolakappi
-
p. 421 - 432
(2015/06/08)
-
- Total synthesis of cannabisin F
-
A practical eight-step synthesis of lignanamide cannabisin F starting from vanillin is reported for the first time. This synthetic strategy applies the aldol reaction followed by the Wittig reaction to afford the key 8-O-4′-neolignan intermediate diacid. The diacid was condensed with N,O-protected tyramine giving, after deprotection, cannabisin F.
- Xia, Ya-Mu,Xia, Jun,Chai, Chen
-
p. 384 - 391
(2014/01/06)
-
- Synthesis of a photocaged tamoxifen for light-dependent activation of Cre-ER recombinase-driven gene modification
-
We report the design of a water-soluble, quaternized tamoxifen photoprobe and demonstrate its application in light-controlled induction of green fluorescent protein expression via a Cre-ER recombinase system. The Royal Society of Chemistry.
- Inlay, Matthew A.,Choe, Veronica,Bharathi, Sophia,Fernhoff, Nathaniel B.,Baker, James R.,Weissman, Irving L.,Choi, Seok Ki
-
p. 4971 - 4973
(2013/07/04)
-
- TREATMENT OF DISEASES BY EPIGENETIC REGULATION
-
The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of cancer, including NUT midline carcinoma, Burkitt's Lymphoma, Acute Myelogenous Leukemia, and Multiple Myeloma; autoimmune or inflammatory diseases or conditions, and sepsis.
- -
-
Paragraph 0664
(2013/11/05)
-
- An efficient one pot syntheses of aryl-3,3′-bis(indolyl)methanes and studies on their spectral characteristics, DPPH radical scavenging-, antimicrobial-, cytotoxicity-, and antituberculosis activity
-
An efficient one-pot syntheses of aryl-3,3′-bis(indolyl)methanes (BIMs) from indole/2-methylindole and formylphenoxyaliphatic acid(s) is described. Esterification of carboxylic acid and aromatic electrophilic substitution reactions are achieved simultaneous in the presence of potash alum as a catalyst. This catalyst could be recovered and reused without substantial loss in its catalytic activity and the methodology could be applied on a range of closely related substrates. The solvation characteristics in ground and excited states of the compounds by monitoring the absorbance and fluorescence band maxima have been studied. The fluorescence studies in protic and aprotic solvents were rationalized on the basis of solute-solvent interaction and substituents effect on these photophysical processes analyzed. The compounds prepared showed efficient antimicrobial effect against human pathogens, cytotoxicity against A431 cell line, and DPPH radical scavenging effect. Single crystal XRD studies have been carried out for a few compounds synthesized in this work.
- Suresh Kumar,Kumaresan,Antony Muthu Prabhu,Bhuvanesh,Seethalakshmi
-
supporting information
p. 254 - 263
(2013/02/23)
-
- Synthesis and Hypolipidemic Activity of Novel 2-(4-(2-Amino-6-(4-Substituted Phenyl) Pyrimidin-4-yl)-2-Substituted Phenoxy) Acetic Acid Derivatives
-
A novel series of 2-(4-(2-amino-6-(4-substituted phenyl) pyrimidin-4-yl)-2-substituted phenoxy) acetic acid derivatives were efficiently synthesized. The synthesized compounds were evaluated for their in vivo hypolipidemic activity, using high-fat-diet-induced hyperlipidemia in rats. Some of these compounds showed significant antihyperlipidemic activity.
- Mokale, Santosh N.,Shete, Maheshwari T.,Shaikh, Sameer I.,Shinde, Devanand B.
-
experimental part
p. 548 - 552
(2012/06/29)
-
- Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate
-
We report the synthesis and in vitro evaluation of folate receptor-targeted nanoconjugate that releases its therapeutic payload via a photochemical mechanism.
- Ki Choi, Seok,Thomas, Thommey,Li, Ming-Hsin,Kotlyar, Alina,Desai, Ankur,Baker Jr., James R.
-
supporting information; experimental part
p. 2632 - 2634
(2010/07/08)
-
- Synthesis of novel unsymmetric bisbenzimidazoles
-
Using chloroacetic acid, p-hydroxyl aromatic aldehydes 1 and aromatic diamines 3 as starting materials, novel bisbenzimidazoles 5 with unsymmetric structure were synthesized via aryloxyacetic acid intermediates 2. Four new intermediates 4 and ten target molecules 5 were characterized by FTIR, 1H NMR, 13C NMR, MS and elemental analysis. Different synthetic methods, including one-pot synthesis and intermittent microwave promotion, were investigated. The research provides a new method and idea for the synthesis of bisbenzimidazoles.
- Mao, Zhengzhoua,Wang, Zhaoyang,Mei, Wenjie,Yang, Kai
-
scheme or table
p. 818 - 824
(2010/11/02)
-
- Heterocyclic analogs of prostaglandines: IV. Synthesis of 3,7-interphenylene 3,10(11)-dioxa-13-azaprostanoids and 9-oxa-7-azaprostanoids based on tetronic acid and aromatic aldehydes
-
An approach was developed to the synthesis of stable in metabolism 3,7-interphenylene 3,10-dioxa-13-aza-and 3,11-dioxa-13-azaprostanoids, and also 9-oxa-7-azaprostanoids with interphenylene and terminal phenyl fragments in the ω-chain based on 3-(alkoxybenzylidene)-and 3-(3-phenylallylidene) tetrahydrofuran-2,4-diones obtained by Knoevenagel condensation of tetronic acid with alkoxy-substituted aromatic aldehydes and cinnamic aldehyde.
- Pashkovskii,Shchukina,Gribovskii,Lakhvich
-
scheme or table
p. 657 - 670
(2009/04/07)
-
- 1,4-dihydropyridine derivatives
-
Compounds a formula (I) STR1 wherein the substituents and symbols have the meanings given in the specification, are new compounds with marked cardiovascular activity.
- -
-
-
- Acidic o-nitroaromatics as photoinhibitors of polymerization in positive working films
-
A photopolymerizable coating composition comprising (1) a nongaseous, ethylenically unsaturated, polymerizable compound, (2) a specified acidic o-nitroaromatic compound, and (3) an organic, radiation-sensitive, free-radical generating system which is useful for making a positive or negative polymeric image on a substrate.
- -
-
-